BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 37662604)

  • 1. Prognostic value of preoperative serological biomarkers in patients undergoing cytoreductive surgery for ovarian cancer peritoneal metastases.
    Khaled C; El Asmar A; Raisi O; Moreau M; Polastro L; Veys I; Pop FC; Donckier V; Liberale G
    Pleura Peritoneum; 2023 Sep; 8(3):133-138. PubMed ID: 37662604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases.
    El Asmar A; Delcourt M; Kamden L; Khaled C; Bohlok A; Moreau M; Sclafani F; Donckier V; Liberale G
    Ann Surg Oncol; 2023 Mar; 30(3):1863-1869. PubMed ID: 36350459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: The prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios.
    Zager Y; Hoffman A; Dreznik Y; Jacoby H; Cordoba M; Horesh N; Nevler A; Gutman M; Berger Y
    Surg Oncol; 2020 Dec; 35():321-327. PubMed ID: 32977104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of pre-operative systemic immune-inflammation index and platelet to lymphocyte ratio in peritoneal carcinomatosis of ovarian origin.
    Ramón-Rodríguez J; De-Armas-Conde N; Jaén-Torrejimeno I; Prada-Villaverde A; Rojas-Holguín A; López-Guerra D; Blanco-Fernández G
    Surg Oncol; 2022 Jun; 42():101750. PubMed ID: 35378377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Bong TSH; Tan GHC; Chia C; Soo KC; Teo MCC
    Int J Clin Oncol; 2017 Jun; 22(3):511-518. PubMed ID: 28138878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of peritoneal scar-like tissue in patients with peritoneal metastases of ovarian origin presenting for curative-intent cytoreductive surgery.
    El Asmar A; Pop F; Helou EE; Demetter P; Veys I; Polastro L; Bohlok A; Liberale G
    World J Surg Oncol; 2023 Aug; 21(1):269. PubMed ID: 37635209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative anemia predicts poor prognosis in patients with endometrial cancer: A systematic review and meta-analysis.
    Abu-Zaid A; Alomar O; Abuzaid M; Baradwan S; Salem H; Al-Badawi IA
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():382-390. PubMed ID: 33529973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer.
    Zhang M; Cheng S; Jin Y; Zhao Y; Wang Y
    Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188503. PubMed ID: 33421585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CA125 and Ovarian Cancer: A Comprehensive Review.
    Charkhchi P; Cybulski C; Gronwald J; Wong FO; Narod SA; Akbari MR
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of epithelial ovarian cancer.
    Kuroki L; Guntupalli SR
    BMJ; 2020 Nov; 371():m3773. PubMed ID: 33168565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma.
    Tong T; Guan Y; Xiong H; Wang L; Pang J
    Front Oncol; 2020; 10():1541. PubMed ID: 33042799
    [No Abstract]   [Full Text] [Related]  

  • 12. Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer.
    Chen J; Li Y; Cui H
    Arch Gynecol Obstet; 2021 Mar; 303(3):767-775. PubMed ID: 33011886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated platelet lymphocyte ratio is a poor prognostic factor in advanced epithelial ovarian cancer.
    Chon S; Lee S; Jeong D; Lim S; Lee K; Shin J
    J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101849. PubMed ID: 32619726
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.